thomas r staab ii cfo and treasurer biocryst pharmaceuticals timesjavascript is disabled market profiles login sign up login sign up   edit person thomas r staab ii cfo and treasurer at biocryst pharmaceuticals location raleighdurham nc add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop thomas r staab ii cfo and treasurer at biocryst pharmaceuticals location raleighdurham nc add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop tom staab joined the biocryst leadership team in july  bringing his skill and experience regarding the financial stewardship of publicallytraded companies development and commercialization of pharmaceutical products and raising capital through strategic partnerships equity and debt financings mr staab most recently served as executive vice president cfo and treasurer of inspire pharmaceuticals from may  through its  million acquisition by merck  co inc in may  prior to joining inspire he held the senior financial positions of acting cfo and treasurer at triangle pharmaceuticals inc through its  million acquisition by gilead sciences inc additionally mr staab spent eight years working for pricewaterhousecoopers llp providing audit and business advisory services to national and multinational corporations in the biotechnology pharmaceutical pulp and paper and communications industries tom currently serves on the board of the nc biosciences organization ncbio and is a member of its audit committee and he has received several awards for his contribution and leadership to other organizations he is a certified public accountant and received a bs in business administration and a masters of accounting from the university of north carolina at chapel hill  companies in career na related markets  colleagues na related investments alias na industry pharmaceuticals tags mergers due diligence pharmaceutical industry forecasting financial modeling venture capital biotechnology topics of influence na na careers achievements investments related people edit view all thomas r staab iicareer  jul biocryst pharmaceuticals cfo and treasurer may to may inspire executive vice president cfo  treasurer may to may inspire pharmaceuticals cfo and treasurer jan to may triangle pharmaceuticals incgilead sciences inc vice president and treasureracting chief financial officer may to jan pricewaterhousecoopers llp manager  tice practice competencies edit view all thomas r staab iieducation  university of north carolina at chapel hill bsba mac business edit thomas r staab iiachievements and recognitions add milestone no milestones has been recorded for thomas r staab ii edit thomas r staab iilinks add link no links has been recorded for thomas r staab ii thomas r staab iiinvestmentsacquisitions no investments has been recorded for thomas r staab ii thomas r staab iiinvestments representing others no investment reps has been recorded for thomas r staab ii thomas r staab iirelated people colleagues at biocryst pharmaceuticals lynne powell chief commercial officer jan robert stoner vice president human resources jan elliott berger sr vice president regulatory affairs  alane barnes vp general counsel and corporate secretary  view all peers  manmeet soni cfo and treasurer of pharmacyclics stuart m huizinga cfo of ehealth dave francis chief financial officer of ehealth david l white cfo of align technology bob goeltz cfo of onyx pharmaceuticals stephen gordon chief financial officer of transmedics view all thomas r staab iirecommended market profiles life sciences kleiner perkins caufield  byers  or more employees  companies staab thomas r ii top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active staab thomas r ii • durham nc how do i update this listing staab thomas r ii is based out of durham summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from staab thomas r ii enter your email address below and choose submit your email cancel contact info staab thomas r ii co inspire pharmaceuticals inc durham nc     business phone  sec sic codebiological products no disgnostic substances recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free thomas staab  north carolina biosciences organization  zoominfocom   biocryst pharmaceuticals inc bcrx senior vice president and cfo staab thomas r iis insider stock buys and sells home homepage membership levels membership data coverage complete stock list founders message the book free trial screeners value screens allinone screener industry overview ben graham netnet undervalued predictable buffettmunger screener magic formula greenblatt historical low ps list historical low pb list peter lynch screen high short interest weekyy lows weekyy highs predictable companies sp  grid dividend stocks spin off list downloads  tools excel addin guruf manual of stocks™ download financial data download guru portfolios download stock pdfs download insider data api mobile app strategies performances buffettmunger undervalued predictable low ps low pb broadest owned most weighted gurus latest guru picks real time picks list of gurus personalize gurus portfolios scoreboard top  holdings view sector picks international picks aggregated portfolio consensus picks guru bargains hot picks industry trends geographic trend etfs options european shorting insiders all insiders ceo buyssales cfo buyssales insider cluster guruinsider double buys triple buyssales insider trends canadian insider dutch insider market market valuation economic data industry overview marketcapgdp valuation global market valuation shiller pe shiller pe by sectors buffett assets allocation by country usa australia canada china germany india japan uk more articles articles editors picks gurufocus research value ideas interviews with gurus top ranked value idea contest videos following authors submit articles writers wanted value contest winners submit articles online my articles conference value conference speakers locationvenue register after conference gathering free drinks tutorials tutorials  webinars faq contact us log in free signup log in day free trial subscribe free trial year refer a friend  earn  search compare search ▾ get day free trial my portfolios▾ portfolios overview create new portfolio portfolio contest my gurus▾ quick browse personalize my gurus premium gurus premium plus investors summarycanadian dutch ceo buys cfo buys insider cluster buys double buys triple buys data export trend saved usa canada ukireland europe asia oceania latin america africa currently selected show all countries ▾ purchase to select this region purchase  usa otcpk nas nyse arca otcbb amex bats purchase to select this region purchase  canada tsxv tsx xcnq purchase to select this region purchase  ukireland uk purchase to select this region purchase  europe germany france poland russia sweden turkey bosnia and herzegovina italy luxembourg switzerland belgium greece norway spain denmark bulgaria netherlands romania finland serbia austria croatia portugal slovakia cyprus macedonia slovenia ukraine hungary lithuania latvia malta iceland estonia czech republic all countries ▾ purchase to select this region purchase  asia india japan korea thailand hongkong china taiwan malaysia singapore israel indonesia pakistan vietnam philippines sri lanka kuwait nepal saudi jordan oman iran iraq united arab emirates kazakhstan bahrain all countries ▾ purchase to select this region purchase  oceania australia new zealand purchase to select this region purchase  latin america brazil mexico argentina chile peru columbia jamaica venezuela ecuador purchase to select this region purchase  africa south africa egypt nigeria mauritius morocco zimbabwe kenya tunisia ghana côte divoire set as default insider trades try insider screener biocryst pharmaceuticals inc bcrx senior vice president and cfo staab thomas r iis insider stock buys and sellsto find out why gurufocus thinks data on insider trades is interesting read can aggregated insider trading activities predict the market stocks that both gurus and insiders are buying can aggregated insider trading activities predict the market of different sectors filter by   default search insider trade go select to drill down all market capmicro cap small cap mid cap large cap mega cap sp  companies all sectorsbasic materials consumer cyclical financial services real estate consumer defensive healthcare utilities communication services energy industrials technology display those with at least          shares display stocks that are within please select        of please select week lowyear lowyear lowreal time insider typebuysellinsider sentiment chart recent filings activity total records    page          last   per page ▾      symbol company insider position date buysell shares trade price  cost  price changesince trade  yield  pe market cap m details bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link bcrxbiocryst pharmastaab thomas r iisenior vice presell  link total records    page          last   per page ▾     add this list into my watchlistportfolio  add or remove tickers comma separated up to  symbols bcrx  select destination portfolioyou need to log in to proceed  click the button to finish related news and stories b comment on b b comment on b b note of b b bcm resources corporation provides update on thompson knolls option agreement b bcm resources corporation issues shares for debt b bcm resources corporation grant of incentive stock options b bcm resources corporation arranges shares for debt b bcm resources corporation announces results of annual and special meeting b bcm resources corporation appoints new director and grants incentive stock options b comment on b b bcm resources corporation inland explorations successfully completes geophysical surveys at thompson knolls b bcm resources corporation appoints new director and vp of exploration b bcm resources corporation finalizes thompson knolls agreement  announces nonbrokered private placement b bcm resources corporation clarification of news release announcing finalization of thompson knolls agreement  nonbrokered private placement b bcm resources corporation to option cuau property in utah  only the transactions in open market or private sale at the market prices are included other transactions such as conversion of derivative security or exercise of options are not included insiders are limited to only officers andor directors of the company select portfolios create a new portfolio why you are interested your selection and notes will be stored in your portfolio login to add portfolio get wordpress plugins for easy affiliate links on stock tickers and guru names  earn affiliate commissions by embedding gurufocus charts gurufocus affiliate program earn up to  per referral  learn more home  about   jobs   advertise    site map    term of use    privacy policy     rss    mobile app     email alerts    referral program    affiliate program    faq    contact us      gurufocuscom llc all rights reserved disclaimers gurufocuscom is not operated by a broker a dealer or a registered investment adviser under no circumstances does any information posted on gurufocuscom represent a recommendation to buy or sell a security the information on this site and in its related newsletters is not intended to be nor does it constitute investment advice or recommendations the gurus may buy and sell securities before and after any particular article and report and information herein is published with respect to the securities discussed in any article and report posted herein in no event shall gurufocuscom be liable to any member guest or third party for any damages of any kind arising out of the use of any content or other material published or available on gurufocuscom or relating to the use of or inability to use gurufocuscom or any content including without limitation any investment losses lost profits lost opportunity special incidental indirect consequential or punitive damages past performance is a poor indicator of future performance the information on this site and in its related newsletters is not intended to be nor does it constitute investment advice or recommendations the information on this site is in no way guaranteed for completeness accuracy or in any other way the gurus listed in this website are not affiliated with gurufocuscom llc stock quotes provided by interactive data fundamental company data provided by morningstar updated daily gf chat  × manage bookmarks close feedback thomas r staab ii cpa executive profile  biography  bloomberg july    pm et biotechnology company overview of biocryst pharmaceuticals inc snapshotpeople  overviewboard memberscommittees executive profile thomas r staab ii cpachief financial officer principal accounting officer senior vice president and treasurer biocryst pharmaceuticals incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriesas of fiscal year  background mr thomas r staab also known as tom ii cpa has been the chief financial officer senior vice president and treasurer of biocryst pharmaceuticals inc since july   and also has been its principal accounting officer since january   mr staab has nearly twenty years of finance and biotech accomplishments to biocryst his experience includes equity financing strategic alliances mergers and acquisitions drug commercialization sec reporting treasury  management and investor relations he served as chief financial officer and treasurer of inspire pharmaceuticals inc since may  executive vice president since september   and served as its principal accounting officer he served as vice president of inspire pharmaceuticals inc since may  he joined inspire pharmaceuticals inc in may  previously mr staab held senior financial positions with triangle pharmaceuticals inc he served for five years at triangle as its vice president and treasurer from august  to may  and its acting chief financial officer from july  to may  prior to triangle he served at price waterhouse llp for eight years w here he worked with publicly and privately held companies focusing on audits business advisory and tax services he serves on the board of the north carolina biosciences organization he also serves on the board of the triangle community foundation he is a certified public accountant mr staab received his bs in business administration and master of accounting degrees from the university of north carolina chapel hillread full background corporate headquarters  emperor boulevarddurham north carolina united statesphone fax  board members memberships there is no board members memberships data available education bs university of north carolina at chapel hillmasters degree university of north carolina at chapel hill other affiliations inspire pharmaceuticals inctriangle pharmaceuticals incuniversity of north carolina at chapel hill annual compensation salarytotal annual compensation stocks options all other compensationexercised optionsexercised options valueexercisable optionsexercisable options valueunexercisable optionsunexercisable options valuetotal value of optionstotal number of options total compensation total annual cash compensationtotal short term compensationother long term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationnamepositioncompanycompensationsijmen de vries md mbachairman of management board and chief executive officerpharming group nvkemma walmsley chief executive officer  directorglaxosmithkline plcflemming ornskov md mba mphceo md  executive directorshire plcmjoji nakayama chairman  ceodaiichi sankyo company limitedmcompensation as of fiscal year  sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact biocryst pharmaceuticals inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close thomas r staab ii  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors thomas r staab ii check out list of companies and businesses related to thomas r staab ii find out thomas r staab ii address and contact details view other people related to thomas r staab ii  coworkers colleagues companions etc address co inspire pharmaceuticals inc  emperor blvd  suite  durham  nc companies related to thomas r staab ii cikcompany namepositioncompany addressbiocryst pharmaceuticals incsenior vice president and cfo  emperor boulevard suite  durham inspire pharmaceuticals incchief financial officer  emperor blvd ste  durham  thomas r staab ii on the web persons related to thomas r staab ii  biocryst pharmaceuticals incnamepositioncity capital gp llc owner new york lpnew york lpnew yorkgeorge b abercrombiedirector durhamgeorge b abercrombiedirector chapel hillgeorge b abercrombiedirector chapel hillw james alexandersr vp chief medical officer birminghamyarlagadda s babusenior vp  drug discovery birminghamyarlagadda s babusenior vp  drug discovery durhambaker biotech capital gp llc owner new yorkbaker bros advisors gp llcnew yorkbaker bros advisors llc owner new yorkbaker bros advisors lpnew yorkbaker bros capital gp llc owner new yorkbaker bros capital gp llc owner new yorkbaker bros investments ii lpnew yorkbaker bros investments lpnew yorkbaker brothers life sciences capital gp llc owner new yorkbaker brothers life sciences capital gp llc owner new yorkbaker brothers life sciences lpnew yorkfelix bakerfelix baker owner new yorkfelix bakernew yorkjulian bakerjulian bakernew yorkjulian bakernew yorkbaker  tisch capital gp llc owner new yorkbakertisch investments lpnew yorkalane p barnesvp general counsel  corp sec raleighalane p barnesvp general counsel  corp sec durhamj claude bennettpresident birminghamj claude bennettpresident birminghamj claude bennettchief operating officer birminghamstephen r biggardirector birminghamstephen r biggardirector durhamcharles e buggceo chairman birminghamcharles e buggceo birminghamcharles e buggdirector birminghamfred e cohendirector san franciscofred e cohendirector fort worthmichael a darwincfo birminghammichael a darwincfo  parkway lake drmichael a darwinprincipal accounting officer birminghamstanley c erckdirector gaithersburgstanley c erckdirector birminghamstanley c erckdirector durhamwilliam w featheringilldirector birminghamwilliam w featheringilldirector birminghamwilliam w featheringilldirector birminghamcarl l gordonnew yorkcarl l gordonnew yorkcarl l gordondirector birminghamcarl l gordondirector birminghamstuart grantsr vp  cfo birminghamjohn l higginsdirector durhamjohn l higginsdirector birminghamjohn l higginsdirector bimringhamjohn l higginsdirector birminghamzola p horovitzdirector birminghamzola p horovitzdirector durhamzola p horovitzdirector birminghamnancy j hutsondirector durhamnancy j hutsondirector stoningtonrobert a ingramdirector peder jensendirector durhamkenneth b lee jrdirector kenneth b lee jrdirector durhamrobert s lowreycontroller pao durhamdavid mcculloughvp birminghamdavid mcculloughvp durhammike millsprincipal accounting officer birminghamjonathan m nugentvp corp communications birminghamjonathan m nugentvp corp communications birminghamsanj k pateldirector lexingtonlynne powellsenior vp  cco durhamrandall b riggsvp business development birminghamrandall b riggssenior vp business development birminghamcharles a sandersdirector charles a sandersdirector birminghamcharles a sandersdirector durhambeth c seidenbergdirector birminghamwilliam p sheridansenior vp  cmo birminghamwilliam p sheridansenior vp  cmo durhamjoseph h sherrill jrdirector birminghamjoseph h sherrill jrdirector birminghamwilliam m spencer iiidirector birminghamwilliam m spencer iiidirector birminghamthomas r staab iisenior vice president and cfo durhamthomas r staab iisenior vice president and cfo durhamrandolph c steerdirector birminghamrandolph c steerdirector birminghamjon p stonehousepresident  ceo birminghamjon p stonehousepresident  ceo durhampersons related to thomas r staab ii  inspire pharmaceuticals incnamepositioncitygeorge b abercrombiedirector durhamgeorge b abercrombiedirector raleighadrian adamspresident and ceo durhamadrian adamspresident and ceo raleighadrian adamspresident and ceo raleighmary b bennettexec vp operationscomm durhamrichard boucherrichard boucher chapel hillkim brazzellsr vp of ophthalmic r  d durhamromulus k brazzellevp medical  scientific durhamromulus k brazzellevp medical  scientific raleighromulus k brazzellevp medical  scientific raleighdeerfield capital lpnew yorkdeerfield international ltdroad town tortola ddeerfield international ltdroad town tortolamanagement co ny deerfieldnew yorkdeerfield partners lpnew yorkdeerfield special situations fund international ltdroad town tortoladeerfield special situations fund lpnew yorkrichard m evansvp pharmaceutical development raleighrichard m evansvp pharmaceutical development raleighrichard m evansvp pharmaceutical development durhamjames e flynn owner new yorkkip freydirector chapel hillkip freydirector durhamkip freydirector raleighgreat point partners llc owner greenwichalan f holmerdirector mcleanalan f holmerdirector durhamalan f holmerdirector raleighnancy j hutsondirector durhamnancy j hutsondirector raleighjeffrey r jaygreenwichjeffrey r jaygreenwichjeffrey r jaygreenwichcharles a johnsonevp of rd  chief med ofcr durhamcharles a johnsonevp of rd  chief med ofcr raleighcharles r kayenew yorkcharles r kayenew yorkcharles r kayenew yorkdonald j kellermansenior vp development raleighdonald j kellermansenior vp development durhamdonald j kellermansenior vp development durhamdonald j kellermansenior vp development durhamdonald j kellermansenior vp development durhamrichard s kentdirector durhamrichard s kentdirector durhamrichard s kentdirector raleighandrew i kovenevp  chief admin  legal ofc durhamandrew i kovenevp  chief admin  legal ofc raleighjoseph landynew yorkjoseph landynew yorkjoseph landynew yorkkenneth b lee jrdirector raleighkenneth b lee jrdirector durhamkenneth b lee jrdirector durhamjonathan s leffdirector new yorkjonathan s leffdirector new yorkgregory j mossinghoffpresident durhamgary d novackgary d novackdirector san rafaelbarry g peaexec vp corp dev  gc durhamwilliam r ringowilliam r ringodirector san franciscowilliam r ringodirector durhamwilliam r ringodirector carmelwilliam r ringodirector fremontjoseph k schachlesr vp sales  marketing durhamjoseph k schachleevp pulmonary business durhamjoseph k schachleevp pulmonary business raleighchristy l shafferchristy l shafferchief executive officer durhamchristy l shafferchief executive officer durhamchristy l shafferchief executive officer durhamchristy l shafferchief executive officer durhamchristy l shafferchief executive officer durhamchristy l shafferpresident  ceo durhamjoseph m spagnardisenior vp gc  secretary durhamjoseph m spagnardisenior vp gc  secretary raleighthomas r staab iichief financial officer durhamthomas r staab iievp cfo  treasurer durhamthomas r staab iievp cfo  treasurer raleighw leigh md phd thompsondirector charlestonwarburg pincus  conew yorkwarburg pincus  conew yorkwarburg pincus ix llcnew yorkwarburg pincus ix llcnew yorkwarburg pincus llcnew yorkwarburg pincus llcnew yorkwarburg pincus llcnew yorkwarburg pincus partners llcnew yorkwarburg pincus partners llcnew yorkwarburg pincus private equity ix lp owner new yorkwarburg pincus private equity ix lp owner new yorkbenjamin r yerxasenior vice pres discovery durhambenjamin r yerxaevp  chf research  develop durham request unsuccessful incapsula incident id  biocryst pharmaceuticals inc  leadership team homeabout biocrystcompany overviewpartners  business developmentleadership teamboard of directorscorporate governancecommittee compositioncode of business conductcommittee charterscareersopportunitiesour sciencepipeline  productrapivabnext generation kallikrein inhibitors for haebcxinvestorsanalyst coverageevents  presentationsemail alertsfinancial profileinvestor faqinformation requestnewsproxy onlinesec documentsstock informationcontact irnews  resourceslatest newshae publicationsbcx publications leadership team home  contact us  site map go print this page leadership team leadership team jon p stonehouse president chief executive officer thomas r staab ii senior vice president chief financial officer william p sheridan mb bs senior vice president chief medical officer yarlagadda s babu phd senior vice president drug discovery alane barnes vice president general counsel  corporate secretary elliott berger phd senior vice president regulatory affairs lynne powell senior vice president  chief commercial officer dr carol ohmstede vice president of project management robert stoner vice president human resources jon p stonehouse president chief executive officer jon p stonehouse a pharmaceutical executive for more than  years has strong commercialization financial transaction business development and management expertise he most recently served as senior vice president of corporate development at merck kgaa with responsibility for global licensing and business development corporate mergers and acquisitions corporate strategic planning and alliance management among his accomplishments he was responsible for leading the effort to develop a strategy for merck that significantly changed the company this culminated with the acquisition of serono sa the largest biotechnology company in europe at the time of the agreement back to top thomas r staab ii senior vice president chief financial officer tom staab joined the biocryst leadership team in july  bringing his skill and experience regarding the financial stewardship of publicallytraded companies development and commercialization of pharmaceutical products and raising capital through strategic partnerships equity and debt financings mr staab most recently served as executive vice president cfo and treasurer of inspire pharmaceuticals from may  through its  million acquisition by merck  co inc in may  prior to joining inspire he held the senior financial positions of acting cfo and treasurer at triangle pharmaceuticals inc through its  million acquisition by gilead sciences inc additionally mr staab spent eight years working for pricewaterhousecoopers llp providing audit and business advisory services to national and multinational corporations in the biotechnology pharmaceutical pulp and paper and communications industries tom currently serves on the executive committee of the board of directors of the north carolina biosciences organization “ncbio” as its chairman and previously served as the chairman of its audit committee he is a certified public accountant and received a bs in business administration and a masters of accounting from the university of north carolina at chapel hill back to top william p sheridan mb bs senior vice president chief medical officer dr william sheridan joined biocryst in july  dr sheridan is a seasoned biotechnology professional during a year tenure at amgen dr sheridan organized and led the companys us medical affairs function making significant contributions to the successful launch of many compounds including aranesp® enbrel® kineret® neulasta® and sensipar® and led several product development teams at amgen dr sheridan held titles at the vice president level in north american medical affairs international medical affairs global health economics and outcomes research us medical affairs and product development he played an integral role in building amgens domestic and international medical affairs functions and in forming the health economics and outcomes unit dr sheridan earned his mb bs degree md equivalent at the university of melbourne in victoria australia dr sheridan is a boardcertified fellow of the royal australasian college of physicians fracp with a subspecialty in medical oncology and a fellow of the american college of physicians back to top yarlagadda s babu phd senior vice president drug discovery dr babu directs a team of structural biologists medicinal chemists and research biologists and oversees the structurebased drug discovery program at the company dr babu was biocrysts first fulltime employee having joined the company in  prior to joining biocryst he served five years on the biochemistry faculty at the university of alabama at birmingham uab he obtained his phd from the indian institute of science bangalore and spent three years in the laboratory of molecular biophysics at the university of oxford uk before joining uab he has over  scientific publications in peerreviewed journals and a number of issued and pending patents to his credit back to top alane barnes vice president general counsel  corporate secretary alane barnes joined biocryst in  and is responsible for all legal affairs of the company including but not limited to all contract negotiations sec compliance corporate governance ip strategy and management licensing transactions government contract management and dispute resolution she graduated magna cum laude from cumberland school of law in  and is a member of curia honoris scholar of merit currently she serves on the board of the biotechnology association of alabama and has served as a mentor for alabama launchpad a competition created to fuel the development of companies in alabama mrs barnes has also spoken at national conferences regarding the pharmaceutical business and at other women’s success conferences she is a  graduate of momentum an organization geared toward building leadership in women back to top elliott berger phd senior vice president regulatory affairs dr elliott berger joined biocryst in august  dr berger has more than  years of experience in the pharmaceutical industry including over  years devoted to management of regulatory affairs supporting new drug and biologic development prior to joining biocryst he was vice president regulatory affairs and quality assurance head of global regulatory strategy at emd pharmaceuticals the north american subsidiary of merck kgaa as part of the emd startup team dr berger built and managed the emd regulatory affairs clinical quality assurance and drug safety groups as well as the global regulatory strategy group at emd dr berger submitted and managed over  investigational new drug applications nda in areas of oncology diabetes cardiovascular disease and neurology dr berger also prepared and submitted the nda for cyanokit ® which was approved within  months of submission to the fda prior to emd dr berger was a member of the senior executive team at astra pharmaceuticals most recently serving as vice president regulatory affairsdr berger received both his phd and ms degrees in biometrics as well as his ba degree in mathematics from temple university back to top lynne powell senior vice president  chief commercial officer ms lynne powell joined biocryst pharmaceuticals as senior vice president and chief commercial officer in january  in this role lynne’s primary responsibility will be to formulate biocryst’s global commercial strategy and to build the global organization that launches our oral kallikrein inhibitors for the prophylactic treatment of hereditary angioedema ms powell brings  years of industry experience to biocryst most recently she served as senior vice president of north american commercial operations at csl behring in this role she was accountable for the financial performance and general management of csl behring’s commercial activities within the us and canada throughout her  year career at csl behring ms powell assumed increasing responsibilities within the rd and commercial functions of the organization she has significant global experience gained as vice president global commercial development and head of business development  european marketing ms powell launched five products globally for rare diseases including hereditary angioedema hae prior to csl she held positions of increasing responsibility within glaxowellcome’s commercial strategy and clinical research organizations back to top dr carol ohmstede vice president of project management dr carol ohmstede joined biocryst pharmaceuticals in july  as vice president of project management dr ohmstede has approximately  years of experience in the pharmaceutical industry including  years focused on project  program management of new molecular entities from research through commercialization prior to joining biocryst she was senior director of project and portfolio management – liver diseases at gilead sciences where she directed a team of project managers focused on the development of new drugs against hepatitis c hepatitis b and nonalcoholic steatohepatitis nash as part of the liver diseases team at gilead she was the program manager for the development and launch of sovaldi® and harvoni® for the treatment of chronic hepatitis c previously dr ohmstede was at trimeris where she served in roles of increasing responsibility in project and portfolio management of the hiv fusion inhibitor program resulting in the development and launch of fuzeon® in partnership with hoffmannla roche at biocryst dr ohmstede will oversee the project management of the hae portfolio and coordinate the management of the overall biocryst project portfolio back to top robert stoner vice president human resources mr robert stoner joined biocryst in january  mr stoner brings more than  years of progressive human resources experience to biocryst having worked in a diverse group of industries during his career prior to joining biocryst mr stoner served as senior vice president human resources at smith breeden associates inc an institutional financial management company in chapel hill north carolina prior to joining smith breeden associates mr stoner held the position of vice president human resources at emd pharmaceuticals the north american subsidiary of merck kgaa at emd mr stoner was responsible for human resource functions for multiple locations and was a member of the global hr team coordinating and directing global hr initiatives within north americamr stoner participated in and graduated from the merck university executive management program attending northwestern university kellogg school of management hong kong university of science and technology and insead in paris mr stoner received his bs in business administration from southern illinois university back to top staab thomas r ii  sec form  insider trading screener  openinsider openinsider latest latest cluster buys latest insider trading all filings latest insider purchases latest insider purchases k latest officer purchases k latest ceocfo purchases k latest insider sales latest insider sales k latest officer sales k latest ceocfo sales k top top officer purchases today top officer purchases past week top officer purchases past month top insider purchases today top insider purchases past week top insider purchases past month top insider sales today top insider sales past week top insider sales past month by symbol officer purchases k today officer purchases k past week officer purchases k past month officer sales k today officer sales k past week officer sales k past month officer sales k today no optex officer sales k past week no optex officer sales k past month no optex insider purchases of penny stocks past month insider sales of penny stocks past month charts contact staab thomas r ii  sec form  insider trading screenercik   address  emperor blvd suite  durham nc  general tickers insider sh price  lqdty m date filing date all dates custom latest day last  days last  week last  weeks last  month last  months last  months last  months last  year last  years last  years    trade date all dates custom latest day last  days last  week last  weeks last  month last  months last  months last  months last  year last  years last  years    filing delay n days ago transaction filing p  purchase s  sale a  grant d  sale to iss g  gift f  tax m  option ex x  option ex c  cnv deriv w  inherited no deriv multiple days traded k own chg  industry all sectors except funds agriculture forestry fish mining construction manufacturing transportation  utilities wholesale trade retail trade financial services closedend funds insider title   officer     cob     ceo     pres     coo     cfo     gc     vp   director    own   other group by filing company company totals num filings num insiders num officers traded k own chg  sort by filing date trade date ticker symbol trade value max results page clear realtime csv options alerts  results        tccntdwmms x filing date trade date ticker insider nameinsider title trade type  share price shares traded shares owned own chg value traded d ret w ret m ret m ret d  bcrxstaab thomas r iisvp cfos  saleoe d  bcrxstaab thomas r iisvp cfos  saleoe d  bcrxstaab thomas r iisvp cfos  saleoe d  bcrxstaab thomas r iisvp cfos  saleoe d  bcrxstaab thomas r iisvp cfos  saleoe m  bcrxstaab thomas r iisvp cfos  sale   bcrxstaab thomas r iisvp cfos  sale   bcrxstaab thomas r iisvp cfos  sale   bcrxstaab thomas r iisvp cfos  sale realtime csv options alerts contact us aamended filing dderivative transaction in filing usually option exercise eerror detected in filing mmultiple transactions in filing earliest reported transaction date and weighted average transaction price s  salesale of securities on an exchange or to another persons  saleoesale of securities on an exchange or to another person after option exercisef  taxpayment of exercise price or tax liability using portion of securities received from the companyp  purchasepurchase of securities on an exchange or from another person return to top copyright   openinsidercom all rights reserved